Insmed Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Insmed Stock Summary

Insmed competes with Ascendis Pharma, Apellis Pharmaceuticals, BeiGene, Akero Therapeutics, and Blueprint Medicines. Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey. Insmed operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 613 people.

Insmed Key Financial Ratios

There are many critical financial ratios that Insmed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Insmed Inc reports annually and quarterly.

Insmed Key Balance Sheet Accounts

Insmed Key Income Statement Accounts

Insmed Key Cash Accounts

Insmed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Insmed's current stock value. Our valuation model uses many indicators to compare Insmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insmed competition to find correlations between indicators driving Insmed's intrinsic value. More Info.Insmed Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Insmed's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Insmed by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Insmed Inc Systematic Risk

Today, most investors in Insmed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Insmed's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Insmed growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Insmed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Insmed Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Insmed Inc based on widely used predictive technical indicators. In general, we focus on analyzing Insmed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Insmed's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.